A Phase 1, Randomized, Placebo‐ and Active‐Controlled Crossover Study to Determine the Effect of Single‐Dose Ertugliflozin on QTc Interval in Healthy Volunteers.

Autor: Sahasrabudhe, Vaishali1 Vaishali.Sahasrabudhe@pfizer.com, Saur, Didier2, Matschke, Kyle3, Terra, Steven G.4, Hickman, Anne1, Huyghe, Isabelle5, Shi, Haihong1, Cutler, David L.6
Zdroj: Clinical Pharmacology in Drug Development. Jun2018, Vol. 7 Issue 5, p513-523. 11p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje